Suggest a Guideline Topic
Any group or individual may propose a guideline topic to SIGN.
To propose a topic for SIGN-sponsored guideline development, please complete the proposal form, and return to the SIGN Executive, Gyle Square, 1 South Gyle Crescent, Edinburgh, EH12 9EB.
Only proposals with a completed Declaration of Interests for the principal proposer will be considered. Please read our Policy on Declaration of Competing Interests for further information. Once ratified proposals and Declarations of Interest will be available on the SIGN website until guideline development begins.
If you have any queries, please contact Roberta James, SIGN Programme Lead. (tel: 0131 623 4735, e-mail email@example.com).
KEEPING GUIDELINES CURRENT
Comments on important new evidence in the field that would update any published SIGN guideline are welcome. All comments are considered, either for immediate response or for more detailed consideration on review of the guideline.
To comment on a published guideline please complete a small change proposal form, and return to the SIGN Executive. Once received small change proposals are processed in the same way as full proposals.
Current TOPiC proposals
This table shows the status of topic proposals currently being considered by SIGN. Further information on scoping and the decisions made at each step of the process are recorded on the proposal form. The table was last updated in May 2016.
|Prevention and treatment of patients with episodic and chronic migraine||David Watson||New topic||Accepted||Migraine proposal|
|Early Diagnosis and support of children with fetal alcohol syndrome and fetal alcohol syndrome disorder||Patricia Jackson||New topic||Accepted||FASD proposal|
|Metastatic breast cancer||SIGN 134 guideline development group||New topic||Accepted||Metastatic breast cancer proposal|
|SIGN 54: Perioperative blood transfusion for elective surgery||Douglas Watson||Refresh||Scoping||SIGN 54 periop blood transfusion proposal|
|SIGN 85: Management of transitional cell carcinoma of the bladder||Jon Coldewey||Refresh||Scoping||SIGN 85 bladder cancer proposal|
|Thyroid and adrenal testing and treatment||Anne Peat, Lorraine Cleaver||New||Scoping||Thyroid proposal|
|Delirium||Karen Goudie||New topic||Scoping||Delerium proposal|
|SIGN 109: Management of genital Chlamydia trachomatis infection||Gareth Brown||Refresh||Screening||SIGN 109 chlamydia proposal|
|ADHD in adults||Richard Jones||New topic||Screening||ADHD in adults proposals|
|Harmful drinking||Joyce O'Hare||New topic||Screening||Harmful drinking proposal|
|SIGN 81: Epilepsy in children||Karyn Robertson||Refresh||Screening||SIGN 81 epilepsy in children|
|SIGN 108: Endovascular therapy for stroke||Jonny Downer||Refresh||Screening||SIGN 108 thrombectomy proposal|
|SIGN 108: Management of patients with stroke or TIA: assessment, investigation, immediate management and secondary prevention||Paul Syme||Refresh||On hold||SIGN 108 acute stroke proposal|
|SIGN 122: Prevention and management of venous thromboembolism||Alison Hunter||Refresh||On hold||SIGN 122 VTE proposal|
principles of Topic Selection
Guideline topics are selected for inclusion in the core programme on the basis of burden of disease, the existence of variation in practice, and the potential to improve outcome.
Topic Selection Process
Funding for guideline development
Agreement by SIGN Council does not guarantee funding support for development of the guideline. The funding for the SIGN guideline programme is approved and provided by Healthcare Improvement Scotland.